Related Experiment Video
Updated: Jun 20, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
NORMAL QUALITY OF LIFE AFTER THE COX MAZE PROCEDURE FOR ATRIAL FIBRILLATION
Spencer J Melby1, Andreas Zierer, Jordon G Lubahn
1Washington University School of Medicine, Barnes-Jewish Hospital, 660 S. Euclid Ave., St. Louis, MO 63110, Division of Cardiothoracic Surgery, Department of Surgery.
Insights
The Cox-Maze procedure effectively cures atrial fibrillation. Patients who undergo this surgery achieve a normal quality of life comparable to the general population long after treatment.
Area of Science:
- Cardiology
- Cardiac Surgery
- Quality of Life Research
Background:
- Atrial fibrillation (AF) significantly impairs patient quality of life.
- The Cox-Maze procedure demonstrates high long-term efficacy in curing AF.
- Long-term quality of life outcomes post-Cox-Maze for lone AF remain under-investigated.
Purpose of the Study:
- To assess late-term quality of life in patients who underwent a lone Cox-Maze procedure.
- To compare the quality of life of these patients to the age-matched general US population.
Main Methods:
- A cohort of 163 patients undergoing lone Cox-Maze for AF between 1987-2003 was studied.
- 68 patients completed the Medical Outcomes Study Short Form 36 Health Survey.
- Patient scores were normalized and compared to the general US population using one-sample t-tests, excluding 4 patients with AF recurrence.
Main Results:
- The study included 52 males (81%) with a mean age of 52.6 years.
- Preoperative AF types included paroxysmal (58%) and persistent/permanent (39%).
- At a mean follow-up of 8.7 years, no significant difference in quality of life scores was found between the Cox-Maze group and the general population across eight health domains.
Conclusions:
- The Cox-Maze procedure is effective in achieving long-term atrial fibrillation cure for most patients.
- Patients successfully treated for AF with the Cox-Maze procedure experience a quality of life comparable to the general population.
- This suggests the procedure restores normal health-related quality of life in the long term.
Abstract:
BACKGROUND/OBJECTIVE: Atrial fibrillation(AF) has been shown in numerous studies to significantly decrease patient quality of life. The Cox-Maze procedure has excellent long-term efficacy in curing AF. However, it is unknown whether this procedure improves long-term quality of life in these patients. The purpose of this study was to examine late quality of life in patients that underwent a lone Cox-Maze procedure. METHODS: Between 1987 and 2003, 163 patients underwent a Cox-Maze procedure for lone AF at our institution. Of these, 68 patients agreed and completed the Medical Outcomes Study Short Form 36 Health Survey. Scores from the age-matched general US population were normalized to a mean of 50 and standard deviation of 10 to facilitate comparison. Collected data were compared to the norm-based score for each domain using a one-sample t-test. Four patients were removed from analysis because of AF recurrence. RESULTS: There were 52 males(81%). Mean age was 52.6±9.5 years. Preoperatively, 37 patients(58%) had paroxysmal and 25 patients(39%) had persistent or permanent AF. The mean duration of AF before surgery was 9.8±8.2 years. There was no statistical difference in norm-based scores between the Cox-Maze procedure group and the age-matched general US population in any of the eight health domains at a mean follow-up of 8.7±3.7 years. CONCLUSION: Our results suggest that the Cox-Maze procedure cures atrial fibrillation in the majority of patients, and that those patients that are cured obtain a normal quality of life as compared to the general population at late follow-up.
Related Concept Videos
Mitral Stenosis III: Medical Management
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation III: Medical Management

